Although these aforementioned studies provide evidence for a beneficial role of AT transplantation in obesity- and T2DM-related glucose homoeostasis and vascular dysfunction, the underlying mechanisms of increased AT PAI-1 production and its causative relationship with glucose metabolism remain largely unknown. This evidence concerns the gene SERPINE1 and obesity disorder.